NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar
NovaBay Pharmaceuticals shares fell 10% to $17.21 in premarket trading Monday, following a 102.5% surge Friday on unusually heavy volume. Traders are watching for updates on warrants and share supply after the company disclosed possible new share issuances and a reverse split. NovaBay has not commented on the recent volatility. Fourth-quarter results are expected March 25.